Why are doctors paid less for procedures on women?

A little-known system determines what surgeries are worth. It almost always values men more highly.
oncodaily

ESMO 2026: 5 Phase III Immunotherapy Trials to Watch

Five phase III immunotherapy trials to watch at ESMO 2026, including NADINA, CheckMate 8HW, STARBOARD, DeLLphi-304, and VOLGA ...

IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial

Landmark results from the DeLLphi-305 Phase III trial showed IMFINZI® (durvalumab) plus Amgen’s tarlatamab-dlle demonstrated a statistically significant and highly clinically meaningful improvement in ...
jen.jiji

Drugs: bladder cancer, EU green light for pembrolizumab plus enfortumab vedotin before and after surgery (2)

In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...
afro.who.int

Female Genital Mutilation

Female genital mutilation (FGM) comprises all procedures that involve partial or total removal of the external female genitalia, or other injury to the female genital organs for non-medical reasons.

AstraZeneca to present overall survival data from four pivotal Phase III trials in Presidential Symposia at ESMO 2026 featuring Sone-Ve, IMFINZI® (durvalumab), TAGRISSO ...

AstraZeneca advances its ambition to revolutionize cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...
腾讯网

从开放手术到微创时代的冷静思考

前言：先承认进步，再谈清偏差机器人、腹腔镜手术的发展无疑是外科技术的重要进步。其在术野放大、操作精细、出血减少、术后疼痛减轻及恢复加快等优势，让更多基层医院的医生有机会开展过去只能在大中心完成的复杂术式。然而，随着微创技术的广泛应用，临床上也出现了一 ...

Why I Keep Following 3-D Matrix

From Peptide Science to a Global Biomaterials Business Public information reviewed through 20 October 2026 I am not a ...